NEW YORK, Dec, 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
IntroductionThe Russian pharmaceutical market generated $10.1 billion in sales in 2009, growing by 14.5% between 2008 and 2009. Key growth drivers include a preference for foreign drugs rather than domestically manufactured products. The government has also designated healthcare a strategic priority for the country's future development which is expected to stimulate Russia's pharmaceutical market.
*Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Russia
*Assesses the size of the Russian pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies
*Examines the Russian generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion
*Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis
Private health expenditure accounts for one third of all healthcare costs of which 82%% is met by out-of-pocket costs due to insufficient availability o
Copyright©2010 PR Newswire.
All rights reserved